Osang Healthcare Co.,Ltd

Equities

A036220

KR7036220002

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 23:00:00 26/06/2024 BST			5-day change	1st Jan Change
15,330 ^KRW	+0.20%		+6.31%	+338.00%

06-17	Osang Healthcare Co.,Ltd announces an Equity Buyback for 375,657 shares.	CI
06-17	Osang Healthcare Co.,Ltd authorizes a Buyback Plan.	CI

Zense-Life Inc announced that it has received $60 million in funding from Osang Healthcare Co.,Ltd and other investors

May 21, 2024

Zense-Life Inc announced that it has received $60 million in a round of funding led by new investor, Osang Healthcare Co.,Ltd on May 22, 2024. The transaction also included participation from existing investors.

Latest news about Osang Healthcare Co.,Ltd

Osang Healthcare Co.,Ltd announces an Equity Buyback for 375,657 shares.	06-17	CI
Osang Healthcare Co.,Ltd authorizes a Buyback Plan.	06-16	CI
Zense-Life Inc announced that it has received $60 million in funding from Osang Healthcare Co.,Ltd and other investors	05-21	CI
Kryptos Biotechnologies, Inc. announced that it has received $10 million in funding from Osang Healthcare Co.,Ltd	03-27	CI
Kryptos Biotechnologies, Inc. announced that it expects to receive $27.095308 million in funding from Osang Healthcare Co.,Ltd	03-17	CI

Chart Osang Healthcare Co.,Ltd

Duration

Period

More charts

Company Profile

Osang HealthCare Co Ltd is a Korea-based company primarily engaged in research and development of in vitro diagnostic medical devices. The Company operates through three segments. The Biochemical Diagnostic segment mainly develops products such as personal blood sugar measurement devices, glycated hemoglobin measurement devices, cholesterol measurement devices, liver disease measurement devices, and U-healthcare devices. The Immunodiagnostic segment is mainly engaged in the development of immunodiagnostic devices and measurement sensors. The Molecular Diagnostic segment mainly engages in the development of molecular diagnostic devices and reagents.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
OSANG HEALTHCARE CO.,LTD	+338.00%	154M
BIOMÉRIEUX	-10.34%	11.57B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-12.48%	7.37B
LANTHEUS HOLDINGS, INC.	+31.15%	5.44B
DIASORIN S.P.A.	+0.26%	5.31B
AUTOBIO DIAGNOSTICS CO., LTD.	-18.68%	3.74B
ANDON HEALTH CO., LTD.	+7.43%	2.58B
10X GENOMICS, INC.	-64.53%	2.33B
MYRIAD GENETICS, INC.	+27.01%	2.23B
VITROLIFE AB	-11.15%	2.21B

Diagnostic & Testing Substances